BioNTech SE Announces New CFO

In a strategic move to bolster its leadership, BioNTech SE has announced the appointment of Ramon Zapata-Gomez as its new Chief Financial Officer, effective July 1, 2025. Zapata-Gomez, who currently holds the position of CFO at Novartis's global biomedical research unit, is set to take over from Jens Holstein, who will be retiring at the end of his term.

A Wealth of Experience

Bringing a rich tapestry of experience spanning North America, Europe, and Latin America, Zapata-Gomez is no stranger to the complexities of the global finance landscape. His expertise and leadership are expected to play a pivotal role in BioNTech's ongoing mission to innovate in the biomedical sector.

Leadership's Vote of Confidence

Helmut Jeggle, Chairman of the Supervisory Board, lauded Zapata-Gomez as "an accomplished leader with deep finance expertise," highlighting his keen understanding of market dynamics and his proven ability to lead teams effectively. Echoing the sentiment, Zapata-Gomez expressed his enthusiasm for the opportunity to contribute to BioNTech's noble cause of "improving patients' lives."